News
Testing fexinidazole as a treatment for T.b. rhodesiense sleeping sickness
Published on 23.05.2019
Epicentre is part of the DNDi partnership that is launching a study into fexinidazole as a safe and well tolerated treatment against treat T.b. rhodes...
Human African trypanosomiasis (HAT)
Sleeping sickness
Fexinidazole
DNDi
Lire l'actualité : Testing fexinidazole as a treatment for T.b. rhodesiense sleeping sickness